Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

President nominates HHS assistant secretaries

Executive Summary

President Bush nominates HHS Principal Deputy Assistant Secretary Cristina Beato to be assistant secretary for health July 23. Beato would replace U.S. Surgeon General Richard Carmona, MD, who has been acting assistant secretary since Eve Slater, MD, resigned in February ("The Pink Sheet" Feb. 10, 2003, p. 10). Administration also names Senate Joint Economic Committee Senior Health Economist Michael O'Grady, PhD, to be HHS assistant secretary for planning & evaluation. O'Grady would replace former ASPE Bobby Jindal (1"The Pink Sheet" Feb. 17, 2003, In Brief)...

You may also be interested in...



Vertex board adds former HHS official

Vertex will nominate former HHS Assistant Secretary for Health Eve Slater, MD, to board of directors at annual meeting May 6. Slater served at HHS for a year after a 19-year career at Merck. She left HHS in February 2003 (1"The Pink Sheet" July 28, 2003, In Brief). Vertex also plans to nominate former Pfizer President-Global R&D John Niblack, PhD, to board. Niblack retired from Pfizer in 2002 (2"The Pink Sheet" Oct. 27, 2003, p. 20)...

ASPE returns to Louisiana

HHS Deputy Assistant Secretary for Planning & Evaluation William Raub will be acting assistant secretary during search for a replacement for Bobby Jindal. The former executive director of the bipartisan Medicare commission has decided to return to Louisiana where he is contemplating a run for governor. Jindal is the second HHS assistant secretary to leave this year, following Assistant Secretary for Health Eve Slater (1"The Pink Sheet" Feb. 10, p. 10). Jindal was one of the key advisors on Medicare prescription drug proposals in the Administration; the White House has backed away from providing a detailed legislative proposal for 2003...

Despite 'Remarkable' ROI On Women’s Health Investments, Money Still Lacking

Recent US government initiatives and growing investor interest are important for developing female-specific therapeutics, but funding is not yet where it should be.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS042211

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel